From Big Pharma to biotech: building R&D teams with Sonya Montgomery

‘I’ve always really loved the biotech space,’ says Sonya Montgomery. An experienced Chief Medical Officer (CMO) with a strong focus on genomic medicine for rare diseases, Sonya has over 20 years of experience developing drugs across the US, Canada, the UK, and the Netherlands. Having most recently worked at Evox Therapeutics, Sonya has also offered her services as an independent consultant for the past decade. Paula Doust Alba, CNS & Rare Disease Consultant for our Life Sciences team, was delighted to catch up with Sonya on the Venari Podcast to discuss Sonya’s career to date, her thoughts on building teams in the space, and prevalent trends within research and development.